Literature DB >> 26173002

p16 as a prognostic indicator in ovarian/tubal high-grade serous carcinoma.

James P Beirne1,2, Darragh G McArt3, Jacqueline A James4, Manuel Salto-Tellez4, Perry Maxwell4, W Glenn McCluggage1,2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26173002     DOI： 10.1111/his.12777

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  4 in total

1.  DEF6 expression in ovarian carcinoma correlates with poor patient survival.

Authors:  Phui-Ly Liew; Chih-Yeu Fang; Yu-Chieh Lee; Yi-Chih Lee; Chi-Long Chen; Jan-Show Chu
Journal:  Diagn Pathol       Date:  2016-08-03       Impact factor: 2.644

2.  WT1, p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis.

Authors:  Luis Felipe Sallum; Liliana Andrade; Susana Ramalho; Amanda Canato Ferracini; Rodrigo de Andrade Natal; Angelo Borsarelli Carvalho Brito; Luis Otávio Sarian; Sophie Derchain
Journal:  Oncotarget       Date:  2018-02-19

3.  Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

Authors:  Peter F Rambau; Robert A Vierkant; Maria P Intermaggio; Linda E Kelemen; Marc T Goodman; Esther Herpel; Paul D Pharoah; Stefan Kommoss; Mercedes Jimenez-Linan; Beth Y Karlan; Aleksandra Gentry-Maharaj; Usha Menon; Susanna Hernando Polo; Francisco J Candido Dos Reis; Jennifer Anne Doherty; Simon A Gayther; Raghwa Sharma; Melissa C Larson; Paul R Harnett; Emma Hatfield; Jurandyr M de Andrade; Gregg S Nelson; Helen Steed; Joellen M Schildkraut; Micheal E Carney; Estrid Høgdall; Alice S Whittemore; Martin Widschwendter; Catherine J Kennedy; Frances Wang; Qin Wang; Chen Wang; Sebastian M Armasu; Frances Daley; Penny Coulson; Micheal E Jones; Micheal S Anglesio; Christine Chow; Anna de Fazio; Montserrat García-Closas; Sara Y Brucker; Cezary Cybulski; Holly R Harris; Andreas D Hartkopf; Tomasz Huzarski; Allan Jensen; Jan Lubiński; Oleg Oszurek; Javier Benitez; Fady Mina; Annette Staebler; Florin Andrei Taran; Jana Pasternak; Aline Talhouk; Mary Anne Rossing; Joy Hendley; Robert P Edwards; Sian Fereday; Francesmary Modugno; Roberta B Ness; Weiva Sieh; Mona A El-Bahrawy; Stacey J Winham; Jenny Lester; Susanne K Kjaer; Jacek Gronwald; Peter Sinn; Peter A Fasching; Jenny Chang-Claude; Kirsten B Moysich; David D Bowtell; Brenda Y Hernandez; Hugh Luk; Sabine Behrens; Mitul Shah; Audrey Jung; Prafull Ghatage; Jennifer Alsop; Kathryn Alsop; Jesús García-Donas; Pamela J Thompson; Anthony J Swerdlow; Chloe Karpinskyj; Alicia Cazorla-Jiménez; María J García; Susha Deen; Lynne R Wilkens; José Palacios; Andrew Berchuck; Jennifer M Koziak; James D Brenton; Linda S Cook; Ellen L Goode; David G Huntsman; Susan J Ramus; Martin Köbel
Journal:  J Pathol Clin Res       Date:  2018-09-21

4.  Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2-Sst5).

Authors:  Frediano Inzani; Angela Santoro; Giuseppe Angelico; Angela Feraco; Saveria Spadola; Damiano Arciuolo; Michele Valente; Angela Carlino; Alessia Piermattei; Giulia Scaglione; Giovanni Scambia; Guido Rindi; Gian Franco Zannoni
Journal:  Cancers (Basel)       Date:  2020-05-12       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.